ExpertCare
A high impact medicines optimisation solution for CVD risk management
CVD remains a leading cause of death and disability in the UK. Preventable yet often poorly managed, it drives avoidable admissions, rising costs, and health inequalities—highlighting the urgent need for new, system-wide models of hypertension care.
Every three minutes, someone in the UK dies of a heart attack or stroke. Many deaths are premature and could have been avoided if patient had been optimally treated.
Hypertension and hypercholesterolemia control remains an unmet challenge
CVD drives a dual burden of personal suffering and heavy NHS costs
CVD is a leading cause of death and disability in the UK. Though preventable and treatable, late diagnosis and poor management fuel avoidable admissions, higher costs, and health inequalities – making new system-wide hypertension models essential.
Increasing incidence of CVD, aging population, pressures on primary care – is standard care failing?
Standard care is failing as leading cardiovascular organisations have acknowledged, current approaches are no longer fit for purpose.
A new approach - systemised and automated virtual care works
By automating elements of decision-making and integrating seamlessly with EMIS and SystmOne, ExpertCare enhances workforce productivity, ensures NICE concordance, and enables system-level efficiencies.
How it works
In the clinician workflow, at the point- of-care
ExpertCare is a fast, easy-to-use digital solution that supports clinicians in personalised, evidence-based CVD medicines optimisation by using patient context to enable precise and timely prescribing decisions. It considers:
Comorbidities • therapeutic history • current clinical status • guidelines
Lowestoft PCN: An Example of Success
Lowestoft Hypertension (Healthy Hearts) project. A HTN meds review of 3,600 patients in 7 GP practices over 8-months (Nov 2024 – July 2025). Results: 85.5% of responding patients achieved BP control due to the intervention together with an average drop of 21 mmHg in Systolic and mmHg 10.3 in Diastolic, in patients who had uncontrolled hypertension after first review.
7 GP practices
3.600 patients
85.5% BP control rate achieved
21 mmHg Systolic and 10.3 mmHg diastolic reduction in cohort mean BP
Supports task-shifting and reduces variation in care
ExpertCare combines a rules-based AI optimisation engine with pharmacist-led implementation methodologies to streamline and speed up CVD medicines review and optimisation prescribing.
Tailored patient prescribing
Automatically considers patient demographics and history
Personalised prescribing optimisation is reliant on having access to the right information at the right time. Our super-fast clinical codes search capabilities together with our certified Electronic Health Record integration API gives prescribers instant access to the vital patient information needed to make an accurate prescribing decision.
Guideline driven
Ensures compliance with gold standard guidelines
Medicines is the most common intervention in healthcare and proper medicines prescribing is complicated especially when treating multiple conditions in a single patient. ExpertCare’s digital protocol-driven medication optimisation and intensification solution helps translate evidence-based guidance into common practice ensuring cost-effective treatment outcomes.
Life, time & money saving
Boosts task-shifting and lightens the GP load
Our solution is designed to take the strain of chronic condition medicines management off primary care doctors by boosting task-shifting and empowering nurses and pharmacists to undertake complex prescribing. It bridges gaps in clinician knowledge of evidence-based therapeutic guidelines and reduces variation in healthcare delivery leading to significant gains in patient treatment outcomes and avoids unnecessary costs.
Accredited and safe
Clinical safety, data accuracy and security vital to our approach
The solution has been co-designed with frontline clinicians and health system partners through iterative development and independent usability studies, confirming its intuitiveness, clinical relevance, and benefits for complex patients.
Our health industry standards compliant APIs allows for seamless integrations with leading Electronic Health Records solutions. ExpertCare meets all NHS data and other regulatory requirements including NHSE, MHRA and DTAC.
Massive cost savings
Evidence shows ExpertCare is cost-saving in both the short- and long-term
Independent evaluations, show ExpertCare delivers immediate and long-term savings, halving the cost of hypertension and cholesterol reviews. Across thousands of patients, it consistently improves blood pressure control (average 20mmHg systolic reduction in uncontrolled patients), achieves an ROI of £2.60 per £1 spent, and reduces vascular events—extending life expectancy and narrowing health inequalities.
Medicines optimisation. When everyone benefits.
Ensuring that patients are prescribed the right medicines, at the right time, in the right doses.
Lowering blood pressure and lipids reduces the risk of heart disease, stroke and death
It’s about you, me, and the ones we love
ExpertCare ensures optimum therapeutic outcomes for patients through improved medication use and reduces the risk of adverse events. Our patient-centered process creates treatment plans focused on each patient’s medication-related goals. This eliminates variations and inequalities in care.
Alleviates GP practice pressures
Boosts practice productivity and income
Beyond improving outcomes, ExpertCare saves clinician time and costs, empowers pharmacy teams with evidence-based recommendations, standardised workflows, and robust analytics to reduce risk, optimise therapy, and enhance patient care.
"Cardiovascular disease (CVD) detection and management is the most impactful area for saving lives over the next decade."
Source: NHS England
Suboptimal medicine use drives hospitalisations, costs, and poor adherence. Improving prescribing and monitoring enhances outcomes, efficiency, and ensures patients and healthcare payers gain greater value from investments in medicines and care.
Flexible deployment models enabling delivery at scale
Whether a single GP practice, a Primary Care Network, Neighbourhood or ICS, ExpertCare offers a range of flexible deployment models—standalone, turnkey, or mentored—ensuring that health system – big or small can adopt the solution in alignment with resources and priorities.
1.
Solution only:
The practice conducts the process in-house, supported by EC, with a flat per-patient fee covering solution support and maintenance.
2.
Turnkey service:
DXS delivers a complete “virtual always” hypertension control programme using contracted clinical pharmacists, priced per registered patient.
3.
Mentor mode:
A blended approach where PCNs provide staff (e.g. ARRS-funded pharmacists or prescribing nurses) while DXS supplies training, mentorship, and project management, with a per-patient fee.
Outcomes are transparent, measurable, and contractually defined, with embedded tracking systems providing auditable data across patient engagement, control rates, NICE compliance, and practice resource utilisation.
From Evidence to Action
ExpertCare has been extensively tested in real-world settings, proving its clinical value, seamless workflow integration, and ability to generate the evidence needed for wider commissioning. Co-designed with frontline clinicians and health system partners, and refined through independent usability studies, it is intuitive, clinically relevant, and effective for managing complex patients.
2022
The Test: An ExpertCare Beta test project involving six hypertension specialists in five different practices.
Results: User feedback used to drive iterative improvements in the innovation and workflow.
2023
The NIHR Evaluation
A formal real world evaluation funded by a NIHR Innovation (i4i) at the Speed of Translation (FAST) programme and in collaboration Health Innovate East. Involved 300 patients across 4 GP practices.
Results: Confirmed that patients treated in concordance with NICE guidance are more likely to have controlled BP.
2023/24
The Innovate UK Evaluation
An 18-month-long full-blown real-world evaluation involving Health Innovation East and Innovate UK across 10 GP practice and involving 2 000 patients to evidence ExpertCare’s efficacy and cost-effectiveness in managing uncontrolled hypertensive patients to BP control. Results: EC is cost-effective in both the long- and short-term in managing HTN patient to BP control – ROI – £2.60 return for every £1 invested – excludes savings in heart attacks and strokes prevented.
2024/25
Healthy Hearts Implementation
Lowestoft Hypertension (Healthy Hearts) project. A HTN meds review of 3,600 patients in 7 GP practices over 8-months.
Results: 85.5% of responding patients achieved BP control due to the intervention together with an average drop of 21 mmHg in Systolic and mmHg 10.3 in Diastolic, in patients who had uncontrolled hypertension after first review.
About Us
ExpertCare is a DXS International plc product. DXS is a UK-based company with extensive experience in respect of working in health care systems. This extends into the development, deployment, administrative and support and maintenance domains.
It is an NHS accredited suppliers its solutions are listed on several NHS Frameworks including the primary care GPIT-F Framework.
The company’s solutions are deployed at about 2 000 primary care sites (general practices) across the UK that service the primary health care needs of an estimated 17 million patients. Its software solutions comply with all NHSE Digital functional and non-functional requirements.
What ExpertCare Users Have To Say
ExpertCare allows for faster, more confident decisions and saves valuable clinician time. With the time saved, I was able to switch my focus on more complex patients.
Meropi Stamna
Clinical Pharmacist (IP)
ExpertCare is fast, accurate, and reliable. It is a game changer.
Head of Operations
Lead Clinical Pharmacist (IP)
I can confidently say that it has drastically reduced the time required to make clinical decisions in hypertensive patients.
Clinical Pharmacist (IP)
ExpertCare has changed our practice for the best. We now save time and money. We can't image life without ExpertCare.
Ahmad Moukli
Physician
Frequently asked questions
All your questions answered.
What is ExpertCare?
DXS ExpertCare is an expert system which provides prescribing advice with the dual objectives of controlling the patient’s blood pressure to an appropriate target, whilst also achieving conformance with treatments recommended by NICE for the management of hypertension and relevant comorbidities.
What is unique about ExpertCare?
Unlike other clinical decision support software which makes recommendations based on one comorbidity at a time, ExpertCare will make a recommendation based on any combination of the following conditions:
- Diabetes (all types)
- Proteinuria (defined as an ACR › 30)
- Angina
- Myocardial Infarction (recent (i.e. ‹ 1year) and past (i.e. › 1year))
- Atrial fibrillation
- Heart failure
ExpertCare thus overcomes one of the main criticisms of NICE, that the guidelines are monothematic, and therefore difficult to implement in real-world situations where patients have comorbidities.
Why have the above conditions been chosen?
The six conditions listed above have been chosen for the following reasons:
- They have a significant impact on hypertension treatment decisions
- NICE makes recommendations on appropriate prescribing for these conditions
- Hypertension management needs to consider the wider risks conferred by comorbidity
Does ExpertCare provide prescribing advice?
ExpertCare interprets the patient’s coded electronic record to infer the presence of any condition which might influence the treatment of hypertension and provides context sensitive advice taken from the SPC of all drugs used in the treatment of hypertension.
The clinician is notified of
- Drug indications, cautions and contraindications
- Advice on initiation, monitoring and discontinuation
- Routine dosage advice
- Dose adjustments required in the presence of renal or hepatic impairment
However, it is up to the prescriber to evaluate this information based on clinical context. For example, childhood asthma might be a caution to the issue of a beta-blocker whereas current asthma would be a contraindication.
What happens if a prescriber wants to keep a drug due to an indication not covered by NICE
The prescriber can continue a hypertension drug for any indication but will be asked for a reason which will be recorded for the benefit of future users. Further recommendations by ExpertCare will take into consideration the retained drug. For example, clonidine retained for the prophylaxis of migraine.
Does ExpertCare advise on interactions
ExpertCare does not duplicate the functionality of the GP healthcare record where interactions are highlighted when a new drug is added. In our next version of ExpertCare, we will add warnings to flag up the risk of bradycardia with certain drug combinations. Similarly, we will also indicate when there is an increased likelihood of hyperkalaemia.
What happens if the patient prefers not to take the recommended drug class
ExpertCare will record the reason for not taking a drug class to inform future consultations. The clinician can then ask for a further recommendation.
In this situation, ExpertCare is sophisticated in that it always makes recommendations which support the effective management of relevant comorbidity. For example, a patient with hypertension and atrial fibrillation, who opts not to take a beta-blocker, will be recommended a rate-limiting calcium channel blocker instead.
8. What about the ICS preferred drugs within a drug class?
ExpertCare has the functionality to indicate a drug which belongs to a local formulary.